Showing results (21-30 of 138) with videos related to
Sort By:
Pageof 14
Diagnostics (Basel, Switzerland)|June 12, 2026
Traditional and Modern Predictors of Atherosclerotic Cardiovascular Disease in Patients with T2D and MASLDCosmina-Theodora Vulpescu Diaconu, Marius-Costin Chitu, Teodor Salmen, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 26, 2021
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical ReviewDjordje S Popovic, Nikolaos Papanas, Anca Pantea Stoian, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 8, 2022
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)Miodrag Janić, Manfredi Rizzo, Francesco Cosentino, et al.Metabolites|November 18, 2020
Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An OverviewNiki Katsiki, Anca Pantea Stoian, Paschalis Steiropoulos, et al.Journal of Clinical Medicine|April 1, 2020
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 DiabetesAngelo Maria Patti, Ali A Rizvi, Rosaria Vincenza Giglio, et al.Metabolism: Clinical and Experimental|August 19, 2020
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitorsAlexandros Sachinidis, Dragana Nikolic, Anca Pantea Stoian, et al.Metabolism: Clinical and Experimental|June 20, 2020
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetesAnca Pantea Stoian, Alexandros Sachinidis, Roxana Adriana Stoica, et al.Life (Basel, Switzerland)|March 29, 2023
The Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists in the Standard of Care Treatment of Type 2 Diabetes MellitusTeodor Salmen, Florin-Teodor Bobirca, Ioana-Cristina Bica, et al.Experimental and Therapeutic Medicine|April 5, 2021
Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective study in Constanta County, RomaniaMihaela Ionescu, Paris Ionescu, Adrian Paul Suceveanu, et al.Metabolites|February 25, 2022
A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic TherapiesJelena Vekic, Aleksandra Zeljkovic, Khalid Al Rasadi, et al.Pageof 14